Published in Pharmacogenomics on December 01, 2012
Warfarin pharmacogenetics. Trends Cardiovasc Med (2014) 1.57
Race influences warfarin dose changes associated with genetic factors. Blood (2015) 0.96
Potential of a Pharmacogenetic-Guided Algorithm to Predict Optimal Warfarin Dosing in a High-Risk Hispanic Patient: Role of a Novel NQO1*2 Polymorphism. J Investig Med High Impact Case Rep (2016) 0.87
A pharmacogenetics service experience for pharmacy students, residents, and fellows. Am J Pharm Educ (2013) 0.86
Why admixture matters in genetically-guided therapy: missed targets in the COAG and EU-PACT trials. P R Health Sci J (2015) 0.81
Effects of NAD(P)H quinone oxidoreductase 1 polymorphisms on stable warfarin doses in Korean patients with mechanical cardiac valves. Eur J Clin Pharmacol (2015) 0.80
VKORC1 Asp36Tyr geographic distribution and its impact on warfarin dose requirements in Egyptians. Thromb Haemost (2013) 0.78
Race-Specific Influence of CYP4F2 on Dose and Risk of Hemorrhage Among Warfarin Users. Pharmacotherapy (2016) 0.78
A Novel Admixture-Based Pharmacogenetic Approach to Refine Warfarin Dosing in Caribbean Hispanics. PLoS One (2016) 0.78
Genetic determinants of variability in warfarin response after the dose-titration phase. Pharmacogenet Genomics (2016) 0.76
Genetic ancestry as an effect modifier of naltrexone in smoking cessation among African Americans: an analysis of a randomized controlled trial. Pharmacogenet Genomics (2015) 0.75
Impact of CYP2C9, VKORC1 and CYP4F2 genetic polymorphisms on maintenance warfarin dosage in Han-Chinese patients: A systematic review and meta-analysis. Meta Gene (2016) 0.75
Clinical and genetic factors associated with warfarin maintenance dose in northern Chinese patients with mechanical heart valve replacement. Medicine (Baltimore) (2017) 0.75
Warfarin Anticoagulation Therapy in Caribbean Hispanics of Puerto Rico: A Candidate Gene Association Study. Front Pharmacol (2017) 0.75
The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients. Eur J Clin Pharmacol (2017) 0.75
Estimation of the warfarin dose with clinical and pharmacogenetic data. N Engl J Med (2009) 12.63
Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med (2011) 8.75
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2012) 6.24
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin. Clin Pharmacol Ther (2008) 4.54
A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose. PLoS Genet (2009) 4.32
CYP4F2 genetic variant alters required warfarin dose. Blood (2008) 4.23
A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose. Blood (2008) 4.02
A genomewide single-nucleotide-polymorphism panel with high ancestry information for African American admixture mapping. Am J Hum Genet (2006) 3.77
Latino populations: a unique opportunity for the study of race, genetics, and social environment in epidemiological research. Am J Public Health (2005) 3.50
Association of warfarin dose with genes involved in its action and metabolism. Hum Genet (2006) 3.27
Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements. Clin Pharmacol Ther (2006) 3.06
Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups. Blood (2010) 2.93
The largest prospective warfarin-treated cohort supports genetic forecasting. Blood (2008) 2.79
CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant. Mol Pharmacol (2009) 1.92
Genetic and clinical predictors of warfarin dose requirements in African Americans. Clin Pharmacol Ther (2010) 1.88
An ancestry informative marker set for determining continental origin: validation and extension using human genome diversity panels. BMC Genet (2009) 1.80
Racial/ethnic differences in the prevalence of atrial fibrillation among older adults--a cross-sectional study. J Natl Med Assoc (2010) 1.73
Predicting warfarin dosage in European-Americans and African-Americans using DNA samples linked to an electronic health record. Pharmacogenomics (2012) 1.66
VKORC1 haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation. Thromb Haemost (2005) 1.55
Factors influencing warfarin dose requirements in African-Americans. Pharmacogenomics (2007) 1.54
Functional polymorphism in human CYP4F2 decreases 20-HETE production. Physiol Genomics (2007) 1.47
The missing association: sequencing-based discovery of novel SNPs in VKORC1 and CYP2C9 that affect warfarin dose in African Americans. Clin Pharmacol Ther (2011) 1.43
Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase). Br J Cancer (1997) 1.42
Race, genetic West African ancestry, and prostate cancer prediction by prostate-specific antigen in prospectively screened high-risk men. Cancer Prev Res (Phila) (2009) 1.36
Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy. Br J Cancer (1997) 1.32
CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population. Pharmacogenomics (2009) 1.32
Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1. Pharmacogenetics (1999) 1.31
Genome-wide association study identifies genetic determinants of warfarin responsiveness for Japanese. Hum Mol Genet (2010) 1.30
Collection of genomic DNA by the noninvasive mouthwash method for use in pharmacogenetic studies. Pharmacotherapy (2002) 1.28
Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients. Pharmacogenet Genomics (2011) 1.20
Physiogenomic analysis of the Puerto Rican population. Pharmacogenomics (2009) 1.11
A study of the DT-diaphorase activity of warfarin-resistant rats. Eur J Biochem (1972) 1.07
Pharmacogenomics of warfarin dose requirements in Hispanics. Blood Cells Mol Dis (2010) 0.99
Influence of CYP4F2 rs2108622 (V433M) on warfarin dose requirement in Asian patients. Drug Metab Pharmacokinet (2010) 0.98
NAD(P)H:quinone oxidoreductase expression and mitomycin C resistance developed by human colon cancer HCT 116 cells. Cancer Res (1995) 0.97
Pyrosequencing method for genotyping cytochrome P450 CYP2C8 and CYP2C9 enzymes. Clin Chem (2004) 0.91
Higher activity of polymorphic NAD(P)H:quinone oxidoreductase in liver cytosols from blacks compared to whites. Toxicol Lett (2006) 0.89
Admixture and population structure in Mexican-Mestizos based on paternal lineages. J Hum Genet (2012) 0.89
A physiological threshold for protection against menadione toxicity by human NAD(P)H:quinone oxidoreductase (NQO1) in Chinese hamster ovary (CHO) cells. Biochem Pharmacol (2002) 0.89
Quinone oxidoreductases and vitamin K metabolism. Vitam Horm (2008) 0.87
Prediction of warfarin dose reductions in Puerto Rican patients, based on combinatorial CYP2C9 and VKORC1 genotypes. Ann Pharmacother (2012) 0.87
Genotype polymorphisms of GGCX, NQO1, and VKORC1 genes associated with risk susceptibility in patients with large-artery atherosclerotic stroke. Clin Chim Acta (2010) 0.86
Pharmacogenetics of acenocoumarol pharmacodynamics. Clin Pharmacol Ther (2004) 0.80
Pharmacogenetic impact of VKORC1 and CYP2C9 allelic variants on warfarin dose requirements in a hispanic population isolate. Clin Appl Thromb Hemost (2009) 0.79
Haplotypes of VKORC1, NQO1 and GGCX, their effect on activity levels of vitamin K-dependent coagulation factors, and the risk of venous thrombosis. Thromb Haemost (2011) 0.78
Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet (2007) 38.98
From networks to populations: the development and application of respondent-driven sampling among IDUs and Latino gay men. AIDS Behav (2005) 8.81
Control of confounding of genetic associations in stratified populations. Am J Hum Genet (2003) 7.99
Skin pigmentation, biogeographical ancestry and admixture mapping. Hum Genet (2003) 4.67
Large-scale SNP analysis reveals clustered and continuous patterns of human genetic variation. Hum Genomics (2005) 3.77
cis-Regulatory changes in Kit ligand expression and parallel evolution of pigmentation in sticklebacks and humans. Cell (2007) 3.72
Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study. Lancet (2013) 3.21
Fruit and vegetable intake in African Americans income and store characteristics. Am J Prev Med (2005) 3.10
The landscape of recombination in African Americans. Nature (2011) 3.06
Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study. J Clin Oncol (2006) 2.87
Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat Genet (2011) 2.70
Genetic evidence for the convergent evolution of light skin in Europeans and East Asians. Mol Biol Evol (2006) 2.54
Risk compensation is not associated with male circumcision in Kisumu, Kenya: a multi-faceted assessment of men enrolled in a randomized controlled trial. PLoS One (2008) 2.43
A finite mixture model of growth trajectories of adolescent alcohol use: predictors and consequences. J Consult Clin Psychol (2002) 2.24
Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement. Blood (2008) 2.18
Genetic ancestry and the search for personalized genetic histories. Nat Rev Genet (2004) 2.08
Use of tobacco cessation treatments among young adult smokers: 2005 National Health Interview Survey. Am J Public Health (2007) 2.01
The 8818G allele of the agouti signaling protein (ASIP) gene is ancestral and is associated with darker skin color in African Americans. Hum Genet (2005) 1.97
MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis. J Clin Invest (2013) 1.89
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82
HIV infection, sexual risk behavior, and substance use among Latino gay and bisexual men and transgender persons. Am J Public Health (2008) 1.80
A common cardiac sodium channel variant associated with sudden infant death in African Americans, SCN5A S1103Y. J Clin Invest (2006) 1.79
Modeling mood variation associated with smoking: an application of a heterogeneous mixed-effects model for analysis of ecological momentary assessment (EMA) data. Addiction (2009) 1.66
Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor. Mol Pharmacol (2003) 1.65
Factors influencing warfarin dose requirements in African-Americans. Pharmacogenomics (2007) 1.54
Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans. PLoS Genet (2011) 1.54
Human genetic diversity and the nonexistence of biological races. Hum Biol (2003) 1.53
African-derived genetic polymorphisms in TNFAIP3 mediate risk for autoimmunity. J Immunol (2010) 1.52
Long-term impact of Fit and Strong! on older adults with osteoarthritis. Gerontologist (2006) 1.52
Human genetic diversity and the nonexistence of biological races. 2003. Hum Biol (2009) 1.51
Social integration and health: community involvement, stigmatized identities, and sexual risk in Latino sexual minorities. J Health Soc Behav (2010) 1.48
Identification, replication, and fine-mapping of Loci associated with adult height in individuals of african ancestry. PLoS Genet (2011) 1.47
Allelic variation at alcohol metabolism genes ( ADH1B, ADH1C, ALDH2) and alcohol dependence in an American Indian population. Hum Genet (2003) 1.39
Risk of nursing home admission among older americans: does states' spending on home- and community-based services matter? J Gerontol B Psychol Sci Soc Sci (2007) 1.36
Replication of prostate cancer risk loci on 8q24, 11q13, 17q12, 19q33, and Xp11 in African Americans. Prostate (2010) 1.32
Genetic heterogeneity in colorectal cancer associations between African and European americans. Gastroenterology (2010) 1.31
COX-2 gene promoter haplotypes and prostate cancer risk. Carcinogenesis (2004) 1.30
IGF-1 and IGFBP-3 gene variants influence on serum levels and prostate cancer risk in African-Americans. Carcinogenesis (2007) 1.28
Markers that discriminate between European and African ancestry show limited variation within Africa. Hum Genet (2002) 1.27
Neighborhood change and distant metastasis at diagnosis of breast cancer. Ann Epidemiol (2007) 1.25
Misconceptions about breast lumps and delayed medical presentation in urban breast cancer patients. Cancer Epidemiol Biomarkers Prev (2010) 1.25
The future of warfarin pharmacogenetics in under-represented minority groups. Future Cardiol (2012) 1.25
Fruit and vegetable availability and selection: federal food package revisions, 2009. Am J Prev Med (2012) 1.18
Role of pharmacogenomics in the management of traditional and novel oral anticoagulants. Pharmacotherapy (2011) 1.16
Relationship between tumor DNA methylation status and patient characteristics in African-American and European-American women with breast cancer. PLoS One (2012) 1.15
Mutations in a novel gene encoding a CRAL-TRIO domain cause human Cayman ataxia and ataxia/dystonia in the jittery mouse. Nat Genet (2003) 1.12
Correlates of physical activity in young adult survivors of childhood cancers. Oncol Nurs Forum (2007) 1.11
Results from a prostate cancer admixture mapping study in African-American men. Hum Genet (2009) 1.11
State expenditures on home and community based services and use of formal and informal personal assistance: a multilevel analysis. J Health Soc Behav (2002) 1.11
Feasibility of implementing a comprehensive warfarin pharmacogenetics service. Pharmacotherapy (2013) 1.09
Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans. Pharmacogenet Genomics (2015) 1.08
Fit and Strong!: bolstering maintenance of physical activity among older adults with lower-extremity osteoarthritis. Am J Health Behav (2010) 1.08
Novel single nucleotide polymorphism associations with colorectal cancer on chromosome 8q24 in African and European Americans. Carcinogenesis (2009) 1.08
African ancestry is associated with asthma risk in African Americans. PLoS One (2012) 1.07
Best-practice physical activity programs for older adults: findings from the national impact study. Am J Public Health (2008) 1.07
Place of death among older Americans: does state spending on home- and community-based services promote home death? Med Care (2008) 1.07
Genotype-guided dosing of vitamin K antagonists. N Engl J Med (2014) 1.06
Characteristics of mammography facility locations and stage of breast cancer at diagnosis in Chicago. J Urban Health (2008) 1.06
Adjusting for population structure in admixed populations. Genet Epidemiol (2002) 1.04
Pharmacogenetics and cardiovascular disease--implications for personalized medicine. Pharmacol Rev (2013) 1.04
Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans. Int J Cancer (2008) 1.03
Association of apolipoprotein E genotype with duration of time to achieve a stable warfarin dose in African-American patients. Pharmacotherapy (2011) 1.03
The limits of genome-wide methods for pharmacogenomic testing. Pharmacogenet Genomics (2012) 1.02
Comparison of two health-promotion programs for older workers. Am J Public Health (2011) 1.02
Association of the GGCX (CAA)16/17 repeat polymorphism with higher warfarin dose requirements in African Americans. Pharmacogenet Genomics (2012) 1.02
Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk. Prostate (2010) 1.02
Pharmacogenomics of warfarin dose requirements in Hispanics. Blood Cells Mol Dis (2010) 0.99
ICAM gene cluster SNPs and prostate cancer risk in African Americans. Hum Genet (2006) 0.99
8q24 risk alleles in West African and Caribbean men. Prostate (2012) 0.98
8q24 sequence variants in relation to prostate cancer risk among men of African descent: a case-control study. BMC Cancer (2010) 0.97
Predictors of serum vitamin D levels in African American and European American men in Chicago. Am J Mens Health (2012) 0.96
Generalizability of established prostate cancer risk variants in men of African ancestry. Int J Cancer (2014) 0.96
Neighborhood changes in concentrated immigration and late stage breast cancer diagnosis. J Immigr Minor Health (2011) 0.95
Type 2 deiodinase and host responses of sepsis and acute lung injury. Am J Respir Cell Mol Biol (2011) 0.94
Examination of polymorphic glutathione S-transferase (GST) genes, tobacco smoking and prostate cancer risk among men of African descent: a case-control study. BMC Cancer (2009) 0.93
No association between variant DNA repair genes and prostate cancer risk among men of African descent. Prostate (2010) 0.92
The relationship between "race" and genetics in biomedical research. Curr Hypertens Rep (2007) 0.92
Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases. Prostate (2008) 0.91
Association of census tract-level socioeconomic status with disparities in prostate cancer-specific survival. Cancer Epidemiol Biomarkers Prev (2011) 0.91
Genome-wide linkage of 77 families from the African American Hereditary Prostate Cancer study (AAHPC). Prostate (2007) 0.91
Comparison of two methods of conducting the Fit and Strong! program. Arthritis Rheum (2009) 0.90
Predictors of unstable anticoagulation in African Americans. J Thromb Thrombolysis (2008) 0.90
Prostate cancer susceptibility Loci identified on chromosome 12 in African Americans. PLoS One (2011) 0.89
Comparison of statistical methods for estimating genetic admixture in a lung cancer study of African Americans and Latinos. Am J Epidemiol (2008) 0.89
Seasonal variation in incidence of pediatric medulloblastoma in the United States, 1995-2001. Neuroepidemiology (2007) 0.88
Contribution of higher risk genes and European admixture to Crohn's disease in African Americans. Inflamm Bowel Dis (2012) 0.88
Common vitamin D pathway gene variants reveal contrasting effects on serum vitamin D levels in African Americans and European Americans. Hum Genet (2014) 0.88
Stakeholder views on pharmacogenomic testing. Pharmacotherapy (2013) 0.88
The pharmacokinetics of codeine and its metabolites in Blacks with sickle cell disease. Eur J Clin Pharmacol (2009) 0.88
Genetic variation in vitamin D-related genes and risk of colorectal cancer in African Americans. Cancer Causes Control (2014) 0.87
Pathway analysis of genome-wide data improves warfarin dose prediction. BMC Genomics (2013) 0.87
Smoking and prostate cancer in a multi-ethnic cohort. Prostate (2013) 0.87
Racial disparities in prostate cancer incidence, biochemical recurrence, and mortality. Prostate Cancer (2011) 0.87
Scaling sexual behavior or "sexual risk propensity" among men at risk for HIV in Kisumu, Kenya. AIDS Behav (2008) 0.87